In-vitro prediction of clinical response to chemotherapy in childhood acute leukaemia. I. Combination of daunorubicin, vincristine and prednisolone.
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001856:Bone Marrow Examination; D002648:Child; D002675:Child, Preschool; D046508:Culture Techniques; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use*; D011379:Prognosis; D014750:Vincristine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014750:Vincristine; D011239:Prednisolone